Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Infiltrating Lymphocyte”

239 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 239 results

Testing effectiveness (Phase 2)Looking for participantsNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 245
Testing effectiveness (Phase 2)UnknownNCT03903887
What this trial is testing

Anti-PD1 Antibody-activated TILs in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 20
Early research (Phase 1)Looking for participantsNCT05607095
What this trial is testing

LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma

Who this might be right for
Uveal MelanomaMelanomaMetastatic Uveal Melanoma+1 more
Memorial Sloan Kettering Cancer Center 30
Very early researchLooking for participantsNCT05141474
What this trial is testing

Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors

Who this might be right for
Epithelial Tumors, MalignantMalignant Solid Tumor
Vall d'Hebron Institute of Oncology 10
Very early researchLooking for participantsNCT05831033
What this trial is testing

Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid Tumors

Who this might be right for
Solid Tumor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 16
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Not applicableLooking for participantsNCT06145802
What this trial is testing

Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (gynecological Tumors)

Who this might be right for
Solid TumorGynecological Tumors
Grit Biotechnology 36
Testing effectiveness (Phase 2)Looking for participantsNCT06961357
What this trial is testing

Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 36
Very early researchNot Yet RecruitingNCT05971576
What this trial is testing

A Clinical Study on TILs for the Treatment of Advanced Solid Tumors

Who this might be right for
Solid Tumor
Suzhou BlueHorse Therapeutics Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01045460
What this trial is testing

Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Very early researchNot Yet RecruitingNCT05505812
What this trial is testing

Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer

Who this might be right for
Breast Cancer
The Affiliated Hospital of Qingdao University 10
Not applicableStudy completedNCT04033965
What this trial is testing

Corellation of Mutations, TILs and Age in Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Cooperative Oncology Group 345
Testing effectiveness (Phase 2)Study completedNCT02383498
What this trial is testing

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

Who this might be right for
Chordoma
NantCell, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT06598371
What this trial is testing

KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

Who this might be right for
Select Advanced Solid Tumors
M.D. Anderson Cancer Center 141
Testing effectiveness (Phase 2)Study completedNCT01993719
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
National Cancer Institute (NCI) 33
Not applicableAvailableNCT05398640
What this trial is testing

Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release

Who this might be right for
Unresectable MelanomaMetastatic Melanoma
Iovance Biotherapeutics, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07288203
What this trial is testing

Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

Who this might be right for
Melanoma (Skin Cancer)Unresectable MelanomaMetastatic Melanoma
Iovance Biotherapeutics, Inc. 100
Early research (Phase 1)UnknownNCT01462903
What this trial is testing

Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors

Who this might be right for
Nasopharyngeal CarcinomaHepatocellular CarcinomaBreast Carcinoma
Sun Yat-sen University 20
Early research (Phase 1)UnknownNCT04443296
What this trial is testing

Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma

Who this might be right for
Cervical Carcinoma
Sun Yat-sen University 10
Not applicableLooking for participantsNCT06397963
What this trial is testing

Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours

Who this might be right for
Solid Tumor, Adult
Grit Biotechnology 18
Load More Results